Why Eyenovia (EYEN) Stock Is Getting Hammered Today
I'm PortAI, I can summarize articles.
Eyenovia (EYEN) stock is down 35% today following the company's announcement to sell shares or pre-funded warrants in a best efforts offering to fund the commercialization of Mydcombi, completing a pediatric myopia study, and general corporate purposes. The offering details remain uncertain and are dependent on market conditions. Eyenovia's stock has dropped 64.01% over the past year and 50.35% in the last month. Currently, it has an RSI of 19.09, indicating it is oversold.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Benzinga The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments